shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Notice of Intent to Publish a Funding Opportunity Announcement for Biomedical-engineering Partnership with Industry (U01 Clinical Trial Not Allowed)

    NOT-EB-21-024

    I. George Zubal, Ph.D.

    Opening date 26 Jan 2022, 12:00AM

    Closing date N/A

    Funding Opportunity Number: NOT-EB-21-024

    Opportunity Category: Discretionary

    CFDA Number(s): 93.286 -- Discovery and Applied Research for Technological Innovations to Improve Human Health

    Cost Sharing or Matching Requirement: No

    Posted Date: Jan 26, 2022 12:00:00 AM EST

    Closing Date: N/A

    Eligible Applicants: Small businesses,Native American tribal governments (Federally recognized),Private institutions of higher education,Public and State controlled institutions of higher education,Independent school districts,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,County governments,For profit organizations other than small businesses,State governments,Public housing authorities/Indian housing authorities,Native American tribal organizations (other than Federally recognized tribal governments),Others (see text field entitled "Additional Information on Eligibility" for clarification)

    Description: The National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Cancer Institute (NCI), National Eye Institute (NEI), National Institute on Aging (NIA), and National Institute of Environmental Health Sciences (NIEHS) intend to reissue modified versions of the Bioengineering Research Partnership Funding Opportunity Announcement(FOA) �Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed) and Bioengineering Research Partnerships (U01 Clinical Trial Required) with new FOAs entitled, Bioengineering Partnership with Industry (BPI), whose goal is to drive the development and speed the adoption of promising tools and technologies that can address important biomedical problems for which insufficient or no solutions exist.The use of engineering principles is encouraged to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need. A key change compared with prior Bioengineering Research Partnership FOAs is that BPI applications must include at least one academic and one industrial organization. The purpose of the BPI FOA will be to encourage applications to: 1) establish a robust engineering solution to a problem in biomedical research or the the practice of medicin; 2) develop a strategic alliance of multi-disciplinary partners based on a well-defined leadership plan; and 3) realize a specific endpoint within 5-10 years based on a detailed plan with a timeline and quantitative milestones. The areas of research encouraged in this initiative must be consistent with the missions of the IC�s participating in the BPI funding opportunity. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in February 2022 with an expected application due date in May 2022. This FOA will utilize the U01activity code.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept